Abstract | BACKGROUND/AIM: METHODS: The records (between January 2015 and January 2017) of 110 patients (55 patients with AVF and 55 patients with tCVC) under hemodialysis therapy for at least 6 months were evaluated retrospectively. The data about blood tests, hospitalizations, and mortality were compared between patients with AVF and tCVC. FINDINGS: Fifty-five patients (25 male, 58 ± 14 years old) were undergoing hemodialysis via AVF. Fifty-five patients (17 male, 63 ± 14 years old) were undergoing hemodialysis via tunneled CVCs. Thirty (54.5%) of the hospitalization patients had AVF and 46 (83.6%) had CVCs (p < 0.01). The only independent predictor of hospitalization was the use of tCVC as vascular access, according to multivariate regression analysis (p = 0.01). Seven (30%) of the dead patients had AVF and 16 (69.6%) had CVCs (p = 0.035). Use of tCVC appeared to be a mortality predictor in univariate regression analysis (p = 0.039). But the significance did not continue in multivariate model (p = 0.578) in which the duration of hemodialysis appeared as the only significant factor (p = 0.002). CONCLUSION: Patients undergoing hemodialysis via AVF had fewer all-cause hospitalizations and mortality rate than those using tunneled CVCs.
|
Authors | Serhat Celik, Ebru Gok Oguz, Gulay Ulusal Okyay, Tamer Selen, Mehmet Deniz Ayli |
Journal | The International journal of artificial organs
(Int J Artif Organs)
Vol. 44
Issue 4
Pg. 229-236
(Apr 2021)
ISSN: 1724-6040 [Electronic] United States |
PMID | 32962489
(Publication Type: Journal Article)
|
Topics |
- Arteriovenous Shunt, Surgical
(adverse effects, methods)
- Catheterization, Central Venous
(adverse effects)
- Duration of Therapy
- Female
- Humans
- Kidney Failure, Chronic
(mortality, therapy)
- Male
- Middle Aged
- Prognosis
- Renal Dialysis
(adverse effects, instrumentation, methods)
- Retrospective Studies
- Vascular Access Devices
(adverse effects)
|